•
Dec 31, 2022

Thermo Fisher Q4 2022 Earnings Report

Reported a 7% increase in revenue, reaching $11.45 billion, and an adjusted EPS of $5.40.

Key Takeaways

Thermo Fisher Scientific reported strong fourth-quarter results, with revenue growing 7% to $11.45 billion and adjusted EPS reaching $5.40. The company highlighted its continued investment in innovation and capacity expansion, as well as its progress on ESG priorities.

Fourth quarter revenue grew 7% to $11.45 billion.

Fourth quarter GAAP diluted earnings per share (EPS) was $4.01.

Fourth quarter adjusted EPS was $5.40.

Core organic revenue growth was 14%.

Total Revenue
$11.5B
Previous year: $10.7B
+7.0%
EPS
$5.4
Previous year: $6.54
-17.4%
Gross Profit
$4.74B
Previous year: $5.4B
-12.3%
Cash and Equivalents
$8.52B
Previous year: $4.48B
+90.4%
Free Cash Flow
$2.94B
Previous year: $1.87B
+57.5%
Total Assets
$97.3B
Previous year: $94.8B
+2.6%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher is initiating revenue and adjusted EPS guidance for the full year 2023. The company expects to achieve 2023 revenue of $45.3 billion and full year Core organic revenue growth of 7%. The company expects to achieve adjusted EPS of $23.70.

Revenue & Expenses

Visualization of income flow from segment revenue to net income